The place of antibiotic therapy in the management of chronic acute exacerbations of chronic bronchitis

International Journal of Antimicrobial Agents

Volumn 18, Issue SUPPL.1, 2001, Pages 49-55

  Akalin, H E ^a  

^a PFIZER INC   (United States)

Author keywords

Acute exacerbations of chronic bronchitis; Chronic obstructive pulmonary disease; Classification; Treatment

Indexed keywords

ANTIINFECTIVE AGENT;

ACUTE DISEASE; BACTERIAL INFECTION; CHRONIC BRONCHITIS; HUMAN; MICROBIOLOGY; REVIEW; UNITED STATES;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRONCHITIS, CHRONIC; HUMANS; UNITED STATES;

EID: 10644226998     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0924-8579(01)00404-6     Document Type: Article

References (29)

1. Sethi S. Infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother 1999;43(Suppl. A):97-105.
2. Gump DW, Phillips CA, Forsyth BR, McIntosh K, Langborn KR, Stouch WH. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976;113:465-74.
3. Monso E, Resell A, Bonet G, et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 1999;13:338-42.
4. Davies BI, Maesen FP, Baur C. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. Eur J Clin Microbiol 1986;5:226-31.
5. Basran GS, Joseph J, Abbas AM, Hughes C, Tillotson GS. Treatment of acute exacerbations of chronic obstructive airways disease - a comparison of amoxycillin and ciprofloxacin. J Antimicrob Chemother 1990;26(Suppl. F): 19-24.
6. Aldons PM. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis. J Antimicrob Chemother 1991;27(Suppl. A):101-8.
7. Bachand RT Jr. Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother 1991;27(Suppl. A):91-100.
8. Lindsay G, Carle WK. Quinolones in general practice. Practitioner 1992;236:876-9.
9. Chodosh S. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis. Am J Med 1993;94(Suppl 3A):131S-5S.
10. Ball P. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis 1994;13:851-6.
11. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998;113:1542-8.
12. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83.
13. Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-20.
14. Smith CB, Golden C, Klauber MR, Kanner R, Renzetti A. Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976;134:552-61.
15. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
16. Balter M, Hyland RH, Low DE, et al. Recommendations on the management of chronic bronchitis: a practical guide for Canadian physicians. Can Med Assoc J 1994;10(Suppl.):1-23.
17. Ball P, Wilson R. Causes, epidemiology, and treatment of bronchial Infections. Infect Med 2000;17:186-98.
18. Balgos A. Guidelines for the role of antibiotics in acute exacerbations of chronic bronchitis in the Asia-Pacific region: report and recommendations of a consensus group. Med Progress 1998;25:29-38.
19. Grossman RF. Cost-effective therapy for acute exacerbations of chronic bronchitis. Semin Respir Infect 2000;15:71-81.
20. Niederman MS. Antibiotic therapy of exacerbations of chronic bronchitis. Semin Respir Infect 2000;15:59-70.
21. Groeneveld K, van Alphen L, Eijk PP, Visschers G, Jansen HM, Zanen HC. Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis 1990;161:512-7.
22. Lomholt H, van Alphen L, Kilian M. Antigenic variation of immunoglobulin Al proteases among sequential isolates of Haemophilus influenzae from healthy children and patients with chronic obstructive pulmonary disease. Infect Immun 1993;61:4575-81.
23. van Alphen L, Jansen HM, Dankert J. Virulence factors in the colonization and persistence of bacteria in the airways. Am J Respir Crit Care Med 1995;151:2094-9.
24. Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. J Am Med Assoc 1995;273:957-60.
25. Wilson R, Grossman R. Introduction: the role of bacterial infection in chronic bronchitis. Semin Respir Infect 2000;15:1-6.
26. Grossman R, Mukherjee J, Vaughan D, et al. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. Chest 1998;113:131-41.
27. Anzueto A, Rizzo JA, Grossman RF. The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis. Clin Infect Dis 1999;28:1344-5.
28. Destache CJ, Dewan N, O'Donohue WJ, Campbell JC, Angelillo VA. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1999;43(Suppl. A):107-13.
29. Rubinstein E. Comparative safety of different macrolides. Infect J Antimicrob Agents 2001;18(Suppl. 1):71-6.